# Evaluation of Improved Onboard Patient Imaging

> **NCT06187103** · — · ACTIVE_NOT_RECRUITING · sponsor: **Varian, a Siemens Healthineers Company** · enrollment: 40 (actual)

## Conditions studied

- Head and Neck Cancer
- Breast Cancer
- Upper Gastrointestinal Cancer
- Lung Cancer
- Pelvic Cancer

## Interventions

- **DEVICE:** HyperSight Imaging

## Key facts

- **NCT ID:** NCT06187103
- **Lead sponsor:** Varian, a Siemens Healthineers Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-10
- **Primary completion:** 2025-12-05
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06187103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06187103, "Evaluation of Improved Onboard Patient Imaging". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06187103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*